SCI Abstract

search
+
Jackfruit waste: an invented anticancer therapy using Jacalin lectin from jackfruit seed
Jackfruit waste: an invented anticancer therapy using Jacalin lectin from jackfruit seed
Every food source contains both edible and inedible waste components. Millions of tonnes of trash fr
A late relapse thymoma and pure red cell aplasia case with an over 5 years of clinical response under everolimus
A late relapse thymoma and pure red cell aplasia case with an over 5 years of clinical response under everolimus
Although several agents showed some clinical activity in patients with recurrent thymoma, there is n
In regard to Cabezas-Camarero et al.
In regard to Cabezas-Camarero et al.
aDepartment of Radiation Oncology, Ankara Etlik State Hospital bDepartment of Radiation Oncology, Hacettepe U...
Cellular responses after (neratinib plus pemetrexed) exposure in NSCLC cells
Cellular responses after (neratinib plus pemetrexed) exposure in NSCLC cells
We previously demonstrated that neratinib interacted with pemetrexed to kill non-small cell lung can
STK25: a viable therapeutic target for cancer treatments?
STK25: a viable therapeutic target for cancer treatments?
Serine/threonine protein kinase 25 (STK25) is a critical regulator of ectopic lipid storage, glucose
APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion: Retraction
APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion: Retraction
The corresponding author has requested retraction of this article [1] as they cannot verify the uniqueness of the images u...
RIDR-PI-103, ROS-activated prodrug PI3K inhibitor inhibits cell growth and impairs the PI3K/Akt pathway in BRAF and MEK inhibitor-resistant BRAF-mutant melanoma cells
RIDR-PI-103, ROS-activated prodrug PI3K inhibitor inhibits cell growth and impairs the PI3K/Akt pathway in BRAF and MEK inhibitor-resistant BRAF-mutant melanoma cells
Reactive oxygen species (ROS) levels are elevated after acquisition of resistance to v-raf murine sa
A novel combination of isovanillin, curcumin, and harmine (GZ17-6.02) enhances cell death and alters signaling in actinic keratoses cells when compared to individual components and two-component combinations
A novel combination of isovanillin, curcumin, and harmine (GZ17-6.02) enhances cell death and alters signaling in actinic keratoses cells when compared to individual components and two-component combinations
Actinic keratosis is a pre-malignant skin disease caused by excessive exposure to ultraviolet light.
Uveitis, a rare but important complication of adjuvant zoledronic acid for early-stage breast cancer
Uveitis, a rare but important complication of adjuvant zoledronic acid for early-stage breast cancer
Bisphosphonates such as zoledronic acid are an important part of adjuvant therapy to reduce the risk
Synthesis and evaluation of novel thiazole moiety-containing compounds as antibreast cancer agents
Progesterone receptor (PR) agonists represent pivotal agents in trapping breast cancer cells through
Circular RNA circ-AGFG1 contributes to esophageal squamous cell carcinoma progression and glutamine catabolism by targeting microRNA-497-5p/solute carrier family 1 member 5 axis
Circular RNA circ-AGFG1 contributes to esophageal squamous cell carcinoma progression and glutamine catabolism by targeting microRNA-497-5p/solute carrier family 1 member 5 axis
Circular RNAs (circRNAs) have been shown to play important regulatory roles in human malignancies. H
Palbociclib enhances the effect of doxorubicin-induced apoptosis in activated B-cell–like diffuse large B-cell lymphoma cells
Palbociclib enhances the effect of doxorubicin-induced apoptosis in activated B-cell–like diffuse large B-cell lymphoma cells
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma around the world. Whil
Identification and validation of RB1 as an immune-related prognostic signature based on tumor mutation burdens in bladder cancer
Identification and validation of RB1 as an immune-related prognostic signature based on tumor mutation burdens in bladder cancer
Bladder cancer (BCa) is one of the most common malignant tumors in the urinary system. Developing ef
Reuse of osimertinib after small cell lung cancer transformation in lung adenocarcinoma with de-novo epidermal growth factor receptor T790M mutation: case report
Reuse of osimertinib after small cell lung cancer transformation in lung adenocarcinoma with de-novo epidermal growth factor receptor T790M mutation: case report
Osimertinib is a third-generation tyrosine kinase inhibitor for non-small cell lung cancer (NSCLC) p
Treatment of metastatic alveolar soft part sarcoma with axitinib and pembrolizumab in an 80-year-old patient with a history of autoimmune disorders
Treatment of metastatic alveolar soft part sarcoma with axitinib and pembrolizumab in an 80-year-old patient with a history of autoimmune disorders
Alveolar soft part sarcoma (ASPS) is a rare malignancy with low sensitivity to chemotherapy. While l
CDKN2B-AS1 is overexpressed in polycystic ovary syndrome and sponges miR-181a to promote granulosa cell proliferation
CDKN2B-AS1 is overexpressed in polycystic ovary syndrome and sponges miR-181a to promote granulosa cell proliferation
MiR-181a suppresses the proliferation of mouse granulosa cells, which participate in polycystic ovar
Butyrate ameliorates colorectal cancer through regulating intestinal microecological disorders
Butyrate ameliorates colorectal cancer through regulating intestinal microecological disorders
The occurrence and progression of colorectal cancer (CRC) are closely related to intestinal microeco
Combination toripalimab and bevacizumab for an elderly urothelial carcinoma patient with brain metastasis who failed rapidly after radiotherapy: a case report and literature review
Combination toripalimab and bevacizumab for an elderly urothelial carcinoma patient with brain metastasis who failed rapidly after radiotherapy: a case report and literature review
Brain metastasis is a rare refractory event in patients with urothelial carcinoma. Platinum-based ch
FXR1 facilitates axitinib resistance in clear cell renal cell carcinoma via regulating KEAP1/Nrf2 signaling pathway
FXR1 facilitates axitinib resistance in clear cell renal cell carcinoma via regulating KEAP1/Nrf2 signaling pathway
Axitinib is emerging as a first-line combination treatment drug for metastatic renal cell carcinoma,
A case of lung adenocarcinoma with MET∆ex14 mutation regressed after preoperative treatment with savolitinib, and successfully underwent radical resection
A case of lung adenocarcinoma with MET∆ex14 mutation regressed after preoperative treatment with savolitinib, and successfully underwent radical resection
Non-small cell lung carcinoma (NSCLC) is a complex disease, with many different potential gene mutat
M2 macrophage-derived exosomal miR-1911-5p promotes cell migration and invasion in lung adenocarcinoma by down-regulating CELF2-activated ZBTB4 expression
M2 macrophage-derived exosomal miR-1911-5p promotes cell migration and invasion in lung adenocarcinoma by down-regulating CELF2-activated ZBTB4 expression
Lung adenocarcinoma (LUAD) is one of the most aggressive, lethal cancers, comprising around 40% of l
format_indent_increase